Article complete

Capgemini’s AI Breakthrough to Accelerate Bioeconomy

This new approach, powered by a specialised protein large language model, predicts the most effective protein variants while using 99% less data than traditional methods.

Capgemini office building with a prominent logo, surrounded by trees and reflections from nearby glass windows.

Key takeaways

  • Capgemini introduces a generative AI method that reduces protein engineering data requirements by 99%.
  • This breakthrough accelerates bioinnovation in healthcare, agriculture, and environmental science.
  • The new methodology addresses data bottlenecks, enabling discoveries with smaller datasets.
  • Enhanced enzyme capabilities could significantly reduce plastic waste management costs.
  • AI predictions streamline research, cutting experiment numbers from thousands to just 43.

Takeaways drafted with AI from the article text.

This new approach, powered by a specialised protein large language model (pLLM), predicts the most effective protein variants while using 99% less data than traditional methods. With a patent pending, this breakthrough is expected to drive innovation across industries such as healthcare, agriculture, and environmental science.

This means organisations can develop new bio-solutions even in resource-limited environments. By reducing research costs and time, this approach allows businesses to explore solutions that were previously too expensive or impractical.

Plastic Waste and Medical Research

The approach enhanced a cutinase enzyme that breaks down PET plastic by 60%, making it easier and more cost-effective to degrade plastic waste. This could help reduce environmental pollution and lower waste management costs.

AI-driven predictions reduced the number of experiments needed to improve the Green Fluorescent Protein (a widely used research marker) from thousands to just 43 while increasing its brightness by seven times. 

This efficiency can speed up drug discovery, diagnostics, and bioengineering applications.

The breakthrough has drawn praise from experts in the field. 

He further mentioned that this breakthrough reflects a clear vision for the future of engineering biology, leveraging the design and engineering of new biocatalysts to enable more sustainable and scalable industrial processes. 

With its expertise and adaptability, Capgemini is well-positioned to drive technological advances in this exciting and rapidly evolving interdisciplinary field.

This breakthrough was developed in Capgemini’s AI-driven biotechnology lab at Cambridge Consultants in the UK. For over ten years, Cambridge Consultants has been pioneering engineering biology and AI development. 

The lab brings together experts in biology, chemistry, AI, digital twins, electronics, and sustainability to push the boundaries of scientific discovery.

Published

Spotted an error? Tell our editors. Read our editorial standards and corrections.

More in this story

AI · 5 stories
  1. Airtel Business Awarded Multi-Year IRSOC Contract to Secure Indian Railways’ Digital Operations
  2. Capgemini to Acquire Singapore-Based Cloud Service Provider Cloud4C 
  3. You are here: Capgemini’s AI Breakthrough to Accelerate Bioeconomy
  4. OpenAI Plans GitHub Rival, Signalling Strategic Shift in Ties With Microsoft
  5. US Orders DeepSeek Removal From Federal Civilian Systems Over National Security Concerns
About the author

Senior Tech Journalist

Shalini is a senior tech journalist, exploring the latest advancements in AI and GCC sector. When she's not reporting on the latest innovations, you can find her immersed in her next literary adventure.

All stories
Belamy · Daily

The day’s AI news, before your first meeting.